MARCH IS COLORECTAL CANCER AND KIDNEY DISEASE AWARENESS MONTH

Unfortunately, colorectal cancer affects both men and women and is the second leading cause of cancer death in the United States. It is necessary to be aware of the importance of colorectal cancer screening, prevention, and treatment. Surgery and chemotherapy have long been primary used for patients with colorectal cancer. However, drug discovery in this field is very promising, and targeted therapy can become a novel approach in treatment.

Kidney disease always develops when kidneys lose their ability to filter waste and performing vital functions that control things like red blood cell production and blood pressure. There are few symptoms of kidney disease progression,  that is why most people should be more attentive to their body and do the annual screening. Now the most promising targets for chronic kidney diseases are ACE2, vitamin D, uric acid, erythropoietin, and phosphate.

ChemDiv can offer the following libraries. They contain small molecules that are capable to target kinases, signaling pathways, and other PPI that are responsible for colorectal and kidney cancer progressions:

https://store.chemdiv.com/catalog/therapeutical_areas/anticancer_library/

https://store.chemdiv.com/catalog/therapeutical_areas/indoleamine_2_3_dioxygenase_1_focused_library/

https://store.chemdiv.com/catalog/focused_and_targeted_libraries/ace2_library/

https://store.chemdiv.com/catalog/focused_and_targeted_libraries/anti_inflammatory_library/